Best in the Diagnostic Substances Industry - Celldex Therapeutics, Palatin Technologies, Quidel

New York, NY -- (SBWIRE) -- 03/04/2013 -- Alpha Penny Stock knows Hot stocks, especially hot Small and Mid-Capstocks, and knows that The RIGHT Stock can offer the HIGHEST percentage gains of any stocks in the market. At AlphaPennyStock, we highlight and alert on the best penny stocks and value investments in stocks on any stock market. The stock picks issued at AlphaPennyStockare the top penny stocks that we are evaluating for the best return on investment.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) jumped +7.77% and closed at $10.26 in the last trading session with the total traded volume of 3.39 million shares. That’s more than the average volume of 1.55 million. The stock extended fall after report that the company is set to release fourth quarter and year end 2012 financial results on Thursday, March 7, 2013 before the opening bell. Celldex executives are going to host a conference call at 8:30 a.m. ET on the same day to discuss 2012 financial and business results where they will also provide an update on key 2013 objectives.

What was the Moving Force behind CLDX On Bullish Run? Read This Research Report on CLDX

CLDX is now trading above its 50 day moving average of +35.62% and 200 day moving average of +74.07%.It has outstanding shares of 80.60 million with the total market cap of $826.96million and its beta value stands at 1.88 times which shows that stock is more volatile.

Palatin Technologies, Inc. (NYSE:PTN) gained 3.30% to close at $0.630 and its overall volume in the last trading session was 2.19 million shares, beating the average volume of 218,127 shares. The stock showed volatility after its bremelanotide 1.25 mg and 1.75 mg doses considerably amplified sexual arousal, sexual desire and the number of sexually satisfying events, and reduced associated distress in premenopausal women with female sexual dysfunction (FSD).

For How Long PTN will Fight for Profitability? Read This Trend Analysis report

PTN hit the day high price of $0.70 and day low of $0.62. The stock is trading with positive year-to-date performance of +5.00%. It has current ratio of 16.21. The company has total market cap of $24.54 million.

Quidel Corporation (NASDAQ:QDEL) added +2.07% on Friday with the closing price of $24.16 before its participation at Cowen Health Care Conference tomorrow at 9:20AM EST. The overall volume in the last trading session was 463,725 shares. Its fifty two week range was $14.92-$24.16. The total market capitalization remained $805.74million.

The stock is ahead its 52 week low with 70.38% and its last month price volatility remained 3.00%. Its beta coefficient was 0.63 with a target price of $24.14. In its share capital, the company has 33.35 million outstanding shares while 28.02 million shares have been floated in market.

Will QDEL Continue To Move Higher? Find Out Here

It has insider ownership of 1.15% with its institutional ownership remained 89.75%. Its current year earnings per share dropped with -34.76% while the five year EPS growth rate was -18.54%.

About Alpha Penny Stock
Alphapennystock.com is an Independent Company, our focus is on small cap stocks that trade on OTCBB and OTC markets, and are mostly referred to as “penny stocks”. These are stocks that normally trade under $5 a share and could offer the greatest potential return on your short or long term investment. We strive to live up to our name, Alpha, being the leader in the industry. It is important to understand that these stocks also carry high risk. You must read our Disclaimer page for more information regarding conflicts of interest and the risks involved.

We try to spot stocks in all types of market conditions. In addition, we provide emerging small cap companies with profiling and investor relations services for compensation. If you believe your company is an emerging company, with a solid product, or a company that offers our members a profitable short or long term opportunity please feel free to send us an e-mail and we’ll review the company and reply to your inquiry promptly. Please provide as much information you believe we’ll need to review your request.